India Orders Sun Pharma to Stop Eye-Care Drug Production Over Quality Issues
India has ordered Sun Pharma to halt production of an eye-care drug at one of its plants due to quality lapses. This move comes amid heightened scrutiny of India's drug quality standards following incidents where locally made cough syrups were linked to child deaths in India and abroad, including Gambia and Uzbekistan.
Hindu Business·




